$41.5MSeries A, 19 November 2025
Funds pipeline acceleration, platform strengthening and partner collaborations.
- Amount
- $41.5M
- Stage
- Series A
- Announced
- 19 November 2025
- Lead
- Mission BioCapital
- Other investors
- Sante Ventures, Lightchain Capital, Cobro Ventures
- Use of funds
- Funds pipeline acceleration, platform strengthening and partner collaborations.
- Checked
- Announced by the company
- Sources
- AI Proteins Raises $41.5M Series A Financing to Advance De Novo Miniproteins as a New Therapeutic Modality - B businesswire.com
AI Proteins Raises $41.5M Series A Financing to Advance De Novo Miniproteins as a New Therapeutic Modality - B news.google.com